The device is expected to improve outcomes for patients undergoing minimally invasive and open craniospinal procedures. Credit: Product Creation Studio/Newswire.

Medical device company PatchClamp Medtech, in partnership with Product Creation Studio, is set to develop a dural repair graft placement system for surgeries.

The system is designed to address the durotomy challenges during cranial and spinal surgeries by providing an immediate watertight seal for durotomies, which are perforations in the dura that can lead to serious complications.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The device employs a unique graft-clasp mechanism that is specifically engineered to facilitate safe and immediate watertight sealing.

This potentially improves outcomes for patients undergoing minimally invasive and open craniospinal procedures.

PatchClamp Medtech co-founder Dr Marc Mayberg said: “Our device is not just a step forward in neurosurgical technology; it is a leap towards fundamentally changing how surgeons approach dural repairs. Achieving a watertight seal in a challenging surgical environment enhances patient safety and recovery, setting a new standard in surgical care.”

Designed for ease of use, the dural repair graft system features a single-hand disposable applicator that allows surgeons to operate effectively in constrained spaces.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

To address the limitations of direct dural repair, the system integrates 3D-printed components with bioresorbable materials that are commercially available, demonstrating its proof of concept through rigorous in vitro and in vivo testing.

Product Creation Studio chief technology officer Scott Thielman said: “Working with the PatchClamp team has been inspiring. Their groundbreaking approach to surgical repair meshes perfectly with our mission to accelerate medical technology development that advances the field and improves patient outcomes.”

The device is yet to receive approval from the US Food and Drug Administration.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact